Used in the treatment of B-cell malignancies and autoimmune disorders such as multiple sclerosis and chronic lymphocytic leukemia. Targets CD20 antigen on B-cells, leading to their depletion through mechanisms like antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. Employed as a reference standard in biosimilar development and analytical testing to ensure consistency and performance of anti-CD20 therapeutics.